Rhumbline Advisers Ars Pharmaceuticals, Inc. Comm Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Rhumbline Advisers holds 65,163 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,163
Previous 63,339 2.88%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
BUY
N/A
1,824 Added 2.88%
65,163 $0
Q3 2024

Nov 12, 2024
SELL
N/A
-2,603 Reduced 3.95%
63,339 $0
Q2 2024

Aug 01, 2024
BUY
N/A
28,888 Added 77.96%
65,942 $0
Q1 2024

May 09, 2024
BUY
N/A
726 Added 2.0%
37,054 $0
Q4 2023

Feb 08, 2024
SELL
N/A
-27 Reduced 0.07%
36,328 $0
Q3 2023

Nov 09, 2023
BUY
N/A
1,924 Added 5.59%
36,355 $0
Q2 2023

Aug 08, 2023
BUY
N/A
34,431 New
34,431 $0
Q2 2022

Aug 11, 2022
SELL
N/A
-24,075 Closed
0 $0
Q1 2022

May 12, 2022
BUY
N/A
2,833 Added 13.34%
24,075 $85,000
Q4 2021

Feb 10, 2022
BUY
N/A
1,229 Added 6.14%
21,242 $141,000
Q3 2021

Nov 12, 2021
BUY
N/A
3,333 Added 19.98%
20,013 $200,000
Q2 2021

Aug 05, 2021
BUY
N/A
3,491 Added 26.47%
16,680 $515,000
Q1 2021

May 06, 2021
BUY
N/A
13,189 New
13,189 $575,000

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email